Physician profile
Armida Priftani
NPI 1831727155
$376.25
in general payments reported to CMS, 2019-2025
13 companies · $212 in 2025
The $212 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $103 · 2024: $61.66 · 2025: $212.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $376.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $376.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $65.95 | 2023-2024 | Cologuard Collection Kit |
| Lilly USA, LLC | $40.10 | 2025 | Mounjaro |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $37.61 | 2023 | Lifevest |
| Novo Nordisk INC | $35.91 | 2025 | |
| Astellas Pharma US INC | $34.63 | 2025 | Veozah |
| Abbott Laboratories | $31.00 | 2024-2025 | Freestyle Libre 3 |
| Scilex Pharmaceuticals INC. | $30.84 | 2025 | |
| Sanofi-Aventis U.S. LLC | $18.81 | 2025 | |
| Merck Sharp & Dohme LLC | $17.88 | 2025 | Capvaxive, Gardasil 9 |
| Dynavax Technologies Corporation | $17.66 | 2025 | Heplisav-B |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.43 | 2023 | Synjardy, Jardiance |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.84 | 2024 | Xifaxan, Trulance |
| Abiomed | $13.59 | 2023 | Impella |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Armida Priftani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.